| DASA3 Stock | | | BRL 2.30 0.01 0.44% |
President
Dr. Octavio Fernandes da Silva Filho serves as Chief Operating Officer of Diagnosticos da America SA since November 26 2009. He joined Laboratorio Bronstein in June 1998 acting as Manager from 1998 to 2001 with responsibility over the medical area and served in a number of positions since then. He obtained a Doctorate of Medicine degree in Clinical Pathology from Universidade do Estado do Rio de Janeiro a Masters degree in Parasitology from Fundacao Oswaldo Cruz and a Doctorate in Philosophy degree in Tropical Medicine from the University of California. In addition he holds an MBA degree in Health Administration and Business Management from Universidade Federal do Rio de Janeiro. since 2009.
| Tenure | 15 years |
| Professional Marks | MBA |
| Phone | 55 11 4197 5500 |
| Web | https://www.dasa3.com.br |
Diagnsticos Management Efficiency
The company has return on total asset
(ROA) of
0.0224 % which means that it generated a profit of $0.0224 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.0458) %, meaning that it generated substantial loss on money invested by shareholders. Diagnsticos' management efficiency ratios could be used to measure how well Diagnsticos manages its routine affairs as well as how well it operates its assets and liabilities.
Diagnsticos da Amrica has accumulated 6.97
B in total debt with debt to equity ratio
(D/E) of 97.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Diagnsticos da Amrica has a current ratio of 1.55, which is within standard range for the sector. Debt can assist Diagnsticos until it has trouble settling it off, either with new capital or with free cash flow. So, Diagnsticos' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Diagnsticos da Amrica sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Diagnsticos to invest in growth at high rates of return. When we think about Diagnsticos' use of debt, we should always consider it together with cash and equity.
Similar Executives
Diagnsticos da Amrica S.A. provides diagnostic test services in Latin America. Diagnsticos da Amrica S.A. is a subsidiary of Cromossomo Participaes II S.A. DASA ON operates under Diagnostics Research classification in Brazil and is traded on Sao Paolo Stock Exchange. Diagnsticos da Amrica (DASA3) is traded on Sao Paulo Exchange in Brazil and employs 24 people.
Management Performance
Diagnsticos da Amrica Leadership Team
Elected by the shareholders, the Diagnsticos' board of directors comprises two types of representatives: Diagnsticos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Diagnsticos. The board's role is to monitor Diagnsticos' management team and ensure that shareholders' interests are well served. Diagnsticos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Diagnsticos' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ricardo Orlando, Chief Information Technology | |
| Octavio Silva, Member of the Executive Board, Vice President of Operations | |
| Pedro Bueno, Chief Executive Officer, Director | |
| Ricardo SIlva, Private and Hospitals Businesses Officer | |
| Emerson Gasparetto, Radiology and Graphic Methods Officer, Member of the Executive Board | |
| Carlos Neto, Chief Director | |
| Linaldo Junior, Chief Officer | |
| Adriano Lima, Executive Vice President of Human Resources | |
| Fbio Cunha, Chief Officer | |
| Felipe Guimaraes, Chief Officer | |
Diagnsticos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Diagnsticos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Diagnsticos Stock Analysis
When running Diagnsticos' price analysis, check to
measure Diagnsticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnsticos is operating at the current time. Most of Diagnsticos' value examination focuses on studying past and present price action to
predict the probability of Diagnsticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnsticos' price. Additionally, you may evaluate how the addition of Diagnsticos to your portfolios can decrease your overall portfolio volatility.